Sign In
Buy TEVA
$34.43
-0.0300 (-0.0871%)
At Close: Aug 04, 2026
Teva's Transformation: From Generics Leader To Branded Drug Innovator
03:05pm, Wednesday, 14'th Aug 2024
Step by step, Teva's management is making progress in transforming it from a generic drugmaker into one that will play a key role in the fight against immune-related disorders. Its revenue was about $
The 7 Best Under $20 Stocks to Buy in August 2024
06:00am, Wednesday, 07'th Aug 2024
Cheap stocks are often cheap for a reason. That bit of investing wisdom underscores the need to perform due diligence on a company and not just buy it because the stock trades at a low price.
What Are the Hottest Biotech Stocks Right Now? 3 Top Picks.
02:22pm, Friday, 02'nd Aug 2024
Sometimes the best way to jump into an industry like biotech is to follow the popular trades. Though that may go against the common advice of avoiding hype cycles and the fear of missing out, seeing w
TEVA Q2 Earnings Beat, Generic Business Drives Sales, Stock Up
10:35am, Thursday, 01'st Aug 2024
TEVA reports better-than-expected second-quarter results, beating both earnings and sales estimates. Management raises the 2024 financial outlook.
Teva Pharmaceutical Industries Limited (TEVA) Q2 2024 Earnings Call Transcript
02:02pm, Wednesday, 31'st Jul 2024
Teva Pharmaceutical Industries Limited (NYSE:TEVA ) Q2 2024 Earnings Conference Call July 31, 2024 8:00 AM ET Company Participants Richard Francis - President & CEO Eli Kalif - CFO Eric Hughes - Head,
Teva Pharma CEO: Majority of momentum came from innovative business, not GLP-1s
12:14pm, Wednesday, 31'st Jul 2024
Richard Francis, Teva Pharma CEO, joins 'Money Movers' to discuss how much of the company's momentum is around its generic obesity drug, the market's excitement around its GLP-1 drug, and much more.
Teva Pharmaceutical Industries (TEVA) Reports Q2 Earnings: What Key Metrics Have to Say
11:01am, Wednesday, 31'st Jul 2024
Although the revenue and EPS for Teva Pharmaceutical Industries (TEVA) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics com
Is Teva Pharmaceutical Industries (TEVA) Stock Undervalued Right Now?
10:46am, Wednesday, 31'st Jul 2024
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Unveiling Teva Pharmaceutical Industries (TEVA) Q2 Outlook: Wall Street Estimates for Key Metrics
10:21am, Monday, 29'th Jul 2024
Evaluate the expected performance of Teva Pharmaceutical Industries (TEVA) for the quarter ended June 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some
Teva's Q2 Outlook: Key Developments In Biosimilars And Pipeline Drugs
07:30am, Friday, 26'th Jul 2024
Teva Pharmaceutical's stock is up 69% since December, driven by legal resolution, blockbuster drugs, debt reduction, and new product launches. Recent developments include the launch of biosimilars and
TEVA's Ajovy Meets Goal in Migraine Prevention Study for Kids
10:02am, Friday, 19'th Jul 2024
TEVA achieves the primary efficacy endpoint with statistical significance in the phase III study of its marketed drug, Ajovy, for the prevention of episodic migraine in pediatric patients.
3 No-Brainer Stocks to Buy With $200 Right Now
05:21am, Wednesday, 17'th Jul 2024
There's never a bad time to put your money to work on Wall Street if you have a long-term mindset. A majority of online brokers have eliminated commission fees on common stock trades and minimum depos
3 Generic Drug Stocks to Watch Amid Improving Market Prospects
01:21pm, Wednesday, 10'th Jul 2024
With the ease in inflationary pressure, the Zacks Medical - Generic Drugs industry is expected to benefit from declining costs. New product launches provide some respite to AMPH, RDY, and TEVA.
Teva Pharmaceuticals Stock: Unlock Value in This Generic Drug Gem
07:14am, Wednesday, 10'th Jul 2024
Drug prices continue to rise, driving up healthcare costs. Pharmaceutical companies usually hike drug prices at the beginning of each year.
Teva to Host Conference Call to Discuss Second Quarter 2024 Financial Results at 8 a.m. ET on July 31, 2024
06:00pm, Tuesday, 02'nd Jul 2024
TEL AVIV, Israel--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its second quarter 2024 financial results on Wednesda
